Chemo Side Affects Washington DC

Studies headed by a doctor at Juntendo University Hospital in Tokyo found that palonosetron was not only as effective as the common anti-nausea drug granisetron at avoiding the sickening side effects in the first 24 hours after chemo.

Local Companies

Northeast Egypt Center
202-388-4770
3937A Minnesota Avenue NE
Washington, DC
Waldorf Health Center
301- 645-6800
Gateway Plaza 3975 St. Charles Parkway
Waldorf, MD
Capital Breast Care Center
(202) 787-5714
650 Pennsylvania Ave., SE Suite 230
Washington, DC
Southern Maryland Vascular Institute
301-768-4455
4255 Altamont Place #101
White Plains, MD
AMERIGROUP District of Columbia
(202) 218-4900
750 1st St., NE
Washington, DC
Wyeth Pharmaceuticals
(202) 288-2890
633 Elliott Street, NE
Washington, DC
District Specific
703-751-6006
1420 West Abingdon Drive Unit 145
Alexandria, VA
James E. Johnson, DDS PC
(202) 783-4567
555 12th Street,
Washington, DC
Providence Hospital
(202) 269-7135
1150 Varnum St., NE
Washington, DC
Health Right, Inc
(202) 218-0373
1101 14th St. NW
Washington, DC

A drug that better prevents the nausea and vomiting that commonly follows chemotherapy treatment for cancer may be on the horizon, Japanese researchers report.

Studies headed by a doctor at Juntendo University Hospital in Tokyo found that palonosetron was not only as effective as the common anti-nausea drug granisetron at avoiding the sickening side effects in the first 24 hours after chemo, but is even better at preventing those side effects in the first five days.

In the phase III trial, about three-fourths of the people given either drug (both given in combination with dexamethasone) did not experience nausea and vomiting in the 24 hours immediately after receiving a chemotherapy regimen that included drugs most likely to cause vomiting -- cisplatin or a combination of anthracycline and cyclophosphamide, according to the study. However, nearly 57 percent of those on palonosetron avoided the ill effects in the first five days after treatment, compared with about 44 percent who had been given the standard granisetron regimen.

The study, which was released online and will appear in the February issue of The Lancet Oncology, reported similar safety records for the two drugs.

More information

The National Cancer Institute has more about chemotherapy side effects.

SOURCE: The Lancet Oncology, news release, Jan. 7, 2009

SOURCE: The Lancet Oncology, news release, Jan. 7, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Featured Local Company

Northeast Egypt Center

202-388-4770
3937A Minnesota Avenue NE
Washington, DC

Related Local Events
EMS Today
Dates: 3/2/2010 - 3/6/2010
Location: Baltimore Convention Center
Baltimore, MD
View Details

American Association of Orthodontists Annual Meeting
Dates: 4/30/2010 - 5/2/2010
Location: Washington Convention Center
Washington, DC
View Details

The 2009 AICR Research Conference on Food, Nutrition, Physical Activity & Cancer
Dates: 11/5/2009 - 11/6/2009
Location: Capital Hilton Hotel, Washington
Washington, DC
View Details

Developmental Interventions in Neonatal Care Conference
Dates: 11/4/2009 - 11/7/2009
Location: Hyatt Regency Crystal City, Washington
Arlington, VA
View Details

AdvaMed - The Med Tech Conference and Advanced Medical Technology Exhibition 2009
Dates: 10/12/2009 - 10/14/2009
Location: Walter E Washington Convention Center
Washington, DC
View Details